OTTER PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Oct 2025)
What this means for you
This application is over — abandoned 20 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97014255
- Mark type
- Stylized text
- Filed
- 07 Sept 2021
- Published for opposition
- 19 Jul 2022
- Abandoned
- 20 Oct 2025
- Attorney of record
- Tim Burgdorf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and management of central nervous system diseases and disorders and neurological disorders; Pharmaceutical preparations for the relief, treatment or amelioration of pain; Analgesic preparations; Anti-inflammatories; Pharmaceutical preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
Owner
- Otter Pharmaceuticals, LLC, Lake Forest, IL, US
- Otter Pharmaceuticals, LLC, Lake Forest, IL, US
Prosecution history
- 21 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Mar 2025 — SOU EXTENSION 5 GRANTED
- 10 Mar 2025 — SOU EXTENSION 5 FILED
- 10 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2025 — SOU EXTENSION 4 GRANTED
- 13 Sept 2024 — SOU EXTENSION 4 FILED
- 13 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Oct 2024 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 14 Oct 2024 — NOTICE OF REVIVAL - E-MAILED
- 14 Oct 2024 — PETITION TO REVIVE-GRANTED
- 14 Oct 2024 — TEAS PETITION TO REVIVE RECEIVED
- 14 Oct 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED